Journal Scans
Longitudinal Changes in Cardiac Function After Cisplatin-Based Chemotherapy for Testicular Cancer
Diastolic Function Declined In Testicular Cancer Patients Following Cisplatin
R Altena, YM Hummel, J Nuver, AJ Smit, JD Lefrandt, RA de Boer, AA Voors, MP van den Berg, EGE de Vries, HM Boezen, JA Gietema
20110729
2011 Aug 29
Ann Oncol
Longitudinal Changes in Cardiac Function After Cisplatin-Based Chemotherapy for Testicular Cancer
Ann Oncol. 2011 Aug 29;[Epub Ahead of Print], R Altena, YM Hummel, J Nuver, AJ Smit, JD Lefrandt, RA de Boer, AA Voors, MP van den Berg, EGE de Vries, HM Boezen, JA Gietema
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
Patients with testicular cancer treated with cisplatin-containing chemotherapy regimens are at increased risk over time for cardiac dysfunction. Subclinical changes in diastolic function may precede systolic failure in patients treated with anthracyclines, but it is unknown how changes in diastolic function change over time in patients treated with chemotherapy. This study investigated changes in cardiac function over time in patients with testicular cancer treated with cisplatin-based chemotherapy,...
